PSADT is vital for monitoring prostate cancer recurrence and guiding treatment decisions, yet often inaccurately calculated by physicians. Inconsistent PSADT documentation can lead to treatment delays ...

The UK National Institute for Health and Clinical Excellence (NICE) guidance recommends conservative management of men with ‘low-risk’ localised prostate cancer, monitoring the disease using ...

We conducted a systematic review of studies published before March 2007 in which a PSA dynamic (velocity or doubling time) was calculated in patients before definitive treatment, a subsequent event ...

UB researchers have developed a new method to more accurately predict tumor growth rates, a crucial statistic used to schedule screenings and set dosing regimens in cancer treatment. The mathematical ...